Stock NBY NOVABAY PHARMACEUTICALS
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. NovaBay Pharmaceuticals

Equities

NBY

US66987P3001

Market Closed - Nyse
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.0788 USD +2.34% Intraday chart for NovaBay Pharmaceuticals -4.37% -61.37%
Mar. 26 Transcript : NovaBay Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 26, 2024
Mar. 26 NovaBay Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ladenburg Thalmann Cuts Price Target on NovaBay Pharmaceuticals to $3.80 From $6, Maintains Buy Rating
MT
NOVABAY PHARMACEUTICALS : Ladenburg Thalmann Adjusts NovaBay Pharmaceuticals PT to $2.20 From $1.90, Maintains Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NBY Stock
  4. News NovaBay Pharmaceuticals
  5. Analyst Reco.